Endpoint
Postoperative atrial fibrillation incidence
CAT:outcome/postoperative-atrial-fibrillation-incidencereported in proportion1 finding from 1 compound
What moved it
How to read these marks1 finding · 1 compound · by evidence strength
| Compound | Direction | Findings | Strongest evidence |
|---|---|---|---|
| quercetin | down | 1 | Evidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers. |
Reported to move it
1 finding
quercetin — decreases
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Post-operative atrial fibrillation incidence was significantly lower with quercetin, representing 4% of the patients compared to 18% in the placebo group (p = 0.033).”
Quoted verbatim from Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients.. - Study
- RCT
- Dose
- 500 mg twice daily
- Population
- Patients undergoing coronary artery bypass graft surgery for coronary artery disease (78 men of 97), quercetin or placebo from two days pre-surgery through hospital discharge
Quercetin Reduces Vascular Senescence and Inflammation in Symptomatic Male but Not Female Coronary Artery Disease Patients.2025PMID:40375481Permalink
How it is measured
Proportion of surgical patients developing new-onset atrial fibrillation during the postoperative period, ascertained by continuous cardiac monitoring or ECG per the trial's stated criteria. The surgical setting (commonly cardiac or coronary-artery-bypass surgery) is recorded with each finding.
Sources cited
1 paper
- Subject
- postoperative atrial fibrillation incidence
- Findings
- 1
- Papers
- 1